SpectraGenics Inc is developer of OTC consumer cosmetic medical devices, has called down around $30 million of a $37 million
By admin at July 29, 2008 | 10:44 pm | Print
What Company Is Offering:
SpectraGenics, a leader in light-based therapeutic beauty devices, gives men and women the freedom to incorporate clinically-proven aesthetic technologies into their personal care regimen with out the inconvenience and investment associated with professional treatments.
How Much They Got From VCs:
SpectraGenics Inc., a Pleasanton, Calif.-based developer of OTC consumer cosmetic medical devices, has called down around $30 million of a $37 million Series E round, according to a regulatory filing. Aisling Capital led the round, and was joined by return backers like De Novo Ventures, Technology Partners, GVC (Japan) and Vivo Ventures.
More at:www.spectragenics.com
admin, 4
hello